Skip to main content

Posts

Nebius (NBIS) Great Growth and Good Value in Q4 2025

Recent posts

AppLovin (APP) Great Growth and Good Value in Q4 2025

AppLovin (NASDAQ: APP) stands out as one of the most profitable and fastest-growing players in digital advertising and app monetization. Despite broader volatility in technology and ad-tech stocks, its Q4 2025 results highlight strong revenue growth, rapid earnings expansion, exceptional margins, and robust free cash flow generation. Although the stock has faced short-term weakness, solid fundamentals and accelerating projections for 2026 suggest AppLovin offers an attractive blend of growth potential and improving valuation. In this article we will dive into AppLovin recent earnings, stock performance & valuation, growth potential, and the risks investor should consider.

Galiano Gold (GAU) Great Growth and Good Value in Q4 2025 Earnings

Galiano Gold (NYSE: GAU) has emerged as one of the more compelling turnaround and growth stories in the mid-tier gold mining sector following its strong Q4 2025 earnings report with revenue grew 147% year over year. After a transformational period that reshaped its asset base and operational structure, the company is now demonstrating meaningful revenue acceleration, improving free cash flow, and strengthening operational execution. With gold prices remaining supportive and analysts projecting solid growth into 2026, Galiano Gold presents an interesting blend of growth and value for investors seeking exposure to the precious metals sector. In this article we will dive into Galiano Gold recent earnings, stock performance & valuation, growth potential, and the risks investor should consider.

SanDisk (SNDK) Great Growth and Good Value (Q2 2026 Earnings)

SanDisk (NASDAQ: SNDK) has quickly emerged as one of the most talked-about semiconductor and storage stocks following its powerful Q2 fiscal 2026 earnings report. After returning to the public market in February 2025, the company has delivered explosive revenue growth, massive EPS expansion, and strong free cash flow generation. With accelerating demand for AI infrastructure, cloud storage, enterprise SSDs, and high-capacity NAND solutions, SanDisk is positioned at the center of several long-term technology megatrends. In this article we will dive into Sandisk recent earnings, stock performance & valuation, growth potential, and the risks investor should consider.

Monday.com (MNDY) Good Growth and Good Value in Q4 2025

Monday.com (NASDAQ: MNDY) has been one of the more volatile software stocks since its IPO in 2021. After soaring in its early days as a high-growth SaaS favorite, the stock has significantly corrected, leaving many investors questioning whether the growth story is over. However, the company’s Q4 2025 earnings tell a very different story. Revenue continues to expand at a healthy pace, profitability is improving rapidly with EPS growth of 232%, and free cash flow generation remains strong. In this article we will dive into Monday.com recent earnings, stock performance & valuation, growth potential, and the risks investor should consider.

Barrick Mining (B) Great Growth and Undervalue in Q4 2025

Barrick Mining (NYSE: B) has emerged as one of the most compelling turnaround and growth stories in the global mining sector following its outstanding Q4 2025 earnings report. Barrick stock is up 37% since my recommendation on October 2025. With triple-digit EPS growth, rapidly expanding margins, and analyst forecasts pointing to continued upside in 2026, Barrick Mining is increasingly being recognized as both a growth stock and a value opportunity. In this article we will dive into Barrick Mining recent earnings, stock performance & valuation, growth potential, and the risks investor should consider.

Eli Lilly (LLY) Great Growth and Good Value in Q4 2025

Eli Lilly and Company (NYSE: LLY) has grabbed headlines in early 2026 after reporting exceptionally strong Q4 2025 earnings, marking a milestone in growth and reinforcing its status as a high-growth, innovation-driven healthcare leader. The stock is up 66% since my recommendation in August 2025. The results not only smashed market expectations but also shed light on the company’s robust pipeline, expanding global presence, and strategic positioning in major therapeutic markets such as diabetes, obesity, immunology, and oncology. In this article we will dive into Eli Lilly recent earnings, stock performance & valuation, growth potential, and the risks investor should consider.